002437 誉衡药业
已收盘 10-16 15:00:00
资讯
新帖
简况
10月16日誉衡药业涨7.62%，中证2000ETF广发基金重仓该股
证券之星 · 10-16 16:33
10月16日誉衡药业涨7.62%，中证2000ETF广发基金重仓该股
异动快报：誉衡药业（002437）10月16日9点31分触及涨停板
证券之星 · 10-16 09:35
异动快报：誉衡药业（002437）10月16日9点31分触及涨停板
誉衡药业（002437）披露与首都医科大学签署《技术转让（专利权）合同》公告，10月15日股价下跌0.61%
证券之星 · 10-15
誉衡药业（002437）披露与首都医科大学签署《技术转让（专利权）合同》公告，10月15日股价下跌0.61%
誉衡药业(002437.SZ)拟受让取得《一种钙超载介导神经元死亡的标志物及应用》的专利权
智通财经 · 10-15
誉衡药业(002437.SZ)拟受让取得《一种钙超载介导神经元死亡的标志物及应用》的专利权
股市必读：誉衡药业新发布《董事会薪酬与考核委员会关于2024年限制性股票激励计划预留授予部分第二个限售期解除限售条件成就的核查意见》
证券之星 · 10-14
股市必读：誉衡药业新发布《董事会薪酬与考核委员会关于2024年限制性股票激励计划预留授予部分第二个限售期解除限售条件成就的核查意见》
10月12日誉衡药业跌7.32%，中证2000ETF广发基金重仓该股
证券之星 · 10-12
10月12日誉衡药业跌7.32%，中证2000ETF广发基金重仓该股
9月30日誉衡药业涨5.19%，中证2000ETF广发基金重仓该股
证券之星 · 09-30
9月30日誉衡药业涨5.19%，中证2000ETF广发基金重仓该股
股市必读：誉衡药业（002437）9月29日董秘有最新回复
证券之星 · 09-30
股市必读：誉衡药业（002437）9月29日董秘有最新回复
誉衡药业：公司2026年三季报披露日期为2026年10月28日
证券之星 · 09-29
誉衡药业：公司2026年三季报披露日期为2026年10月28日
誉衡药业：拟于10月28日披露2026年第三季度报告
证券之星 · 09-22
誉衡药业：拟于10月28日披露2026年第三季度报告
9月21日誉衡药业涨7.78%，中证2000ETF广发基金重仓该股
证券之星 · 09-21
9月21日誉衡药业涨7.78%，中证2000ETF广发基金重仓该股
股市必读：誉衡药业新发布《2026年第三次临时股东会法律意见书》
证券之星 · 09-14
股市必读：誉衡药业新发布《2026年第三次临时股东会法律意见书》
誉衡药业（002437）披露2026年第三次临时股东会决议公告，9月11日股价下跌2.25%
证券之星 · 09-11
誉衡药业（002437）披露2026年第三次临时股东会决议公告，9月11日股价下跌2.25%
9月9日誉衡药业跌8.19%，中证2000ETF广发基金重仓该股
证券之星 · 09-09
9月9日誉衡药业跌8.19%，中证2000ETF广发基金重仓该股
9月3日誉衡药业跌6.18%，中证2000ETF广发基金重仓该股
证券之星 · 09-03
9月3日誉衡药业跌6.18%，中证2000ETF广发基金重仓该股
9月2日誉衡药业（002437）龙虎榜数据：机构净卖出6523.81万元，北向资金净买入4.91万元
证券之星 · 09-02
9月2日誉衡药业（002437）龙虎榜数据：机构净卖出6523.81万元，北向资金净买入4.91万元
8月31日誉衡药业（002437）龙虎榜数据：机构净卖出2.15亿元，北向资金净卖出6241.53万元
证券之星 · 08-31
8月31日誉衡药业（002437）龙虎榜数据：机构净卖出2.15亿元，北向资金净卖出6241.53万元
8月31日誉衡药业跌10.08%，中证2000ETF广发基金重仓该股
证券之星 · 08-31
8月31日誉衡药业跌10.08%，中证2000ETF广发基金重仓该股
异动快报：誉衡药业（002437）8月31日11点12分触及跌停板
证券之星 · 08-31
异动快报：誉衡药业（002437）8月31日11点12分触及跌停板
誉衡药业（002437）披露全资子公司签署《终止协议》公告，8月28日股价上涨9.95%
证券之星 · 08-28
誉衡药业（002437）披露全资子公司签署《终止协议》公告，8月28日股价上涨9.95%
加载更多
公司概况
公司名称：
哈尔滨誉衡药业股份有限公司
所属行业：
医药制造业
上市日期：
2010-06-23
主营业务：
哈尔滨誉衡药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是维生素类药物、心脑血管药物、骨科药物、电解质类药物、抗肿瘤药物、抗感染药物、其他用药领域、糖尿病类药物、镇痛类药物。
发行价格：
50.00
{"stockData":{"symbol":"002437","market":"SZ","secType":"STK","nameCN":"誉衡药业","latestPrice":3.53,"timestamp":1792134189000,"preClose":3.28,"halted":0,"volume":601413108,"delay":0,"changeRate":0.0762,"floatShares":2103000000,"shares":2230000000,"eps":0.1801,"marketStatus":"已收盘","change":0.25,"latestTime":"10-16 15:00:00","open":3.35,"high":3.61,"low":3.33,"amount":2135000000,"amplitude":0.0854,"askPrice":3.53,"askSize":15605,"bidPrice":3.52,"bidSize":4068,"shortable":0,"etf":0,"ttmEps":0.1801,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792373400000},"marketStatusCode":5,"adr":0,"adjPreClose":3.28,"symbolType":"stock","openAndCloseTimeList":[[1792114200000,1792121400000],[1792126800000,1792134000000]],"highLimit":3.61,"lowLimit":2.95,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":2229868126,"isCdr":false,"pbRate":2.96,"roa":"--","peRate":19.600222,"roe":"7.18%","epsLYR":0.1719,"committee":0.214042,"marketValue":7871000000,"turnoverRate":0.286,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-20。","floatMarketCap":7422000000},"requestUrl":"/m/hq/s/002437","defaultTab":"news","newsList":[{"id":"2675562769","title":"10月16日誉衡药业涨7.62%，中证2000ETF广发基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675562769","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675562769?lang=zh_cn&edition=full","pubTime":"2026-10-16 16:33","pubTimestamp":1792139596,"startTime":"0","endTime":"0","summary":"证券之星消息，10月16日誉衡药业涨7.62%，收盘报3.53元，换手率28.6%，成交量601.41万手，成交额21.35亿元。重仓誉衡药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的中证2000ETF广发。中证2000ETF广发目前规模为0.76亿元，最新净值1.3114，较上一交易日下跌3.52%，近一年下跌5.53%。中证2000ETF广发的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600027922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0188","BK0239","BK0095","560220","002437","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675554433","title":"异动快报：誉衡药业（002437）10月16日9点31分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2675554433","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675554433?lang=zh_cn&edition=full","pubTime":"2026-10-16 09:35","pubTimestamp":1792114554,"startTime":"0","endTime":"0","summary":"证券之星10月16日盘中消息，9点31分誉衡药业（002437）触及涨停板。其所属行业化学制药目前上涨。领涨股为N联亚。该股为基因测序，PD-1抑制剂，民营医院概念热股，当日基因测序概念上涨3.08%，PD-1抑制剂概念上涨3.04%，民营医院概念上涨1.94%。10月15日的资金流向数据方面，主力资金净流入4252.96万元，占总成交额4.8%，游资资金净流出166.94万元，占总成交额0.19%，散户资金净流出4086.02万元，占总成交额4.62%。近5日资金流向一览见下表：誉衡药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600009968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","BK0028","BK0095","BK0077","BK0188","002437"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675653878","title":"誉衡药业（002437）披露与首都医科大学签署《技术转让（专利权）合同》公告，10月15日股价下跌0.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675653878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675653878?lang=zh_cn&edition=full","pubTime":"2026-10-15 22:08","pubTimestamp":1792073300,"startTime":"0","endTime":"0","summary":"截至2026年10月15日收盘，誉衡药业报收于3.28元，较前一交易日下跌0.61%，最新总市值为73.14亿元。该股当日开盘3.25元，最高3.5元，最低3.23元，成交额达8.85亿元，换手率为12.54%。近日，哈尔滨誉衡药业股份有限公司披露《关于与首都医科大学签署〈技术转让（专利权）合同〉的公告》。公告显示，公司与首都医科大学签署《技术转让（专利权）合同》，以1,115万元受让‘一种钙超载介导神经元死亡的标志物及应用’的专利权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500039296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0095","BK0188","BK0060","BK0028","BK0239","002437","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675896015","title":"誉衡药业(002437.SZ)拟受让取得《一种钙超载介导神经元死亡的标志物及应用》的专利权","url":"https://stock-news.laohu8.com/highlight/detail?id=2675896015","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675896015?lang=zh_cn&edition=full","pubTime":"2026-10-15 19:14","pubTimestamp":1792062854,"startTime":"0","endTime":"0","summary":"智通财经APP讯，誉衡药业 发布公告，公司与首都医科大学签署《技术转让(专利权)合同》。根据《技术转让合同》约定，公司拟以1,115万元人民币的交易价格受让取得《一种钙超载介导神经元死亡的标志物及应用》的专利权。本项目涉及的“一种钙超载介导神经元死亡的标志物”是拟开发用于靶向TLK2的基因治疗疗法，有望切入“独立于降眼压的RGC神经保护” 这一未满足的临床需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1507861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"誉衡药业(002437.SZ)拟受让取得《一种钙超载介导神经元死亡的标志物及应用》的专利权","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0060","BK0188","BK0028","BK0077","002437","BK0095","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675369428","title":"股市必读：誉衡药业新发布《董事会薪酬与考核委员会关于2024年限制性股票激励计划预留授予部分第二个限售期解除限售条件成就的核查意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675369428","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675369428?lang=zh_cn&edition=full","pubTime":"2026-10-14 01:48","pubTimestamp":1791913694,"startTime":"0","endTime":"0","summary":"公司公告汇总：誉衡药业审议通过2024年限制性股票激励计划预留授予部分第二个限售期解除限售事项，涉及35名激励对象、180万股限制性股票，占总股本0.0807%。公司公告汇总董事会薪酬与考核委员会关于2024年限制性股票激励计划预留授予部分第二个限售期解除限售条件成就的核查意见董事会薪酬与考核委员会确认35名激励对象解除限售资格合法有效，解除限售条件已全部成就，同意为其办理1,800,000股限制性股票解除限售事宜，并提交董事会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400001632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0028","BK0077","BK0188","BK0060","BK0095","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674465878","title":"10月12日誉衡药业跌7.32%，中证2000ETF广发基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674465878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674465878?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:44","pubTimestamp":1791794675,"startTime":"0","endTime":"0","summary":"证券之星消息，10月12日誉衡药业跌7.32%，收盘报3.42元，换手率13.19%，成交量277.27万手，成交额9.76亿元。重仓誉衡药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的中证2000ETF广发。中证2000ETF广发目前规模为0.76亿元，最新净值1.4095，较上一交易日上涨0.04%，近一年上涨0.71%。中证2000ETF广发的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200021831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0028","BK0239","560220","BK0077","002437","BK0095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671426274","title":"9月30日誉衡药业涨5.19%，中证2000ETF广发基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671426274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671426274?lang=zh_cn&edition=full","pubTime":"2026-09-30 16:36","pubTimestamp":1790757404,"startTime":"0","endTime":"0","summary":"证券之星消息，9月30日誉衡药业涨5.19%，收盘报3.65元，换手率16.83%，成交量353.81万手，成交额12.77亿元。重仓誉衡药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的中证2000ETF广发。中证2000ETF广发目前规模为0.76亿元，最新净值1.441，较上一交易日上涨0.97%，近一年上涨4.37%。中证2000ETF广发的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000025839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0077","BK0188","BK0239","560220","BK0060","BK0095","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671495362","title":"股市必读：誉衡药业（002437）9月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2671495362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671495362?lang=zh_cn&edition=full","pubTime":"2026-09-30 01:05","pubTimestamp":1790701519,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，誉衡药业报收于3.47元，上涨0.58%，换手率9.05%，成交量190.19万手，成交额6.64亿元。董秘最新回复投资者： 董秘您好！董秘： 您好，公司2026年三季报披露日期为2026年10月28日，感谢关注！交易信息汇总资金流向9月29日主力资金净流入1106.31万元，占总成交额1.67%；游资资金净流入1809.36万元，占总成交额2.73%；散户资金净流出2915.67万元，占总成交额4.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000001678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0077","BK0095","BK0028","BK0239","002437","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671294710","title":"誉衡药业：公司2026年三季报披露日期为2026年10月28日","url":"https://stock-news.laohu8.com/highlight/detail?id=2671294710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671294710?lang=zh_cn&edition=full","pubTime":"2026-09-29 16:15","pubTimestamp":1790669715,"startTime":"0","endTime":"0","summary":"证券之星消息，誉衡药业(002437)09月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问公司26年三季报什么时间披露？誉衡药业回复：您好，公司2026年三季报披露日期为2026年10月28日，感谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900025113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0077","BK0028","002437","BK0060","BK0095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669700112","title":"誉衡药业：拟于10月28日披露2026年第三季度报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2669700112","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669700112?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:27","pubTimestamp":1790065637,"startTime":"0","endTime":"0","summary":"证券之星消息，誉衡药业(002437)09月22日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问公司26年三季报什么时间披露？誉衡药业回复：你好，公司拟于10月28日披露2026年第三季度报告，谢谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200027638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0239","BK0095","BK0028","BK0077","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669447159","title":"9月21日誉衡药业涨7.78%，中证2000ETF广发基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669447159","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669447159?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:44","pubTimestamp":1789980298,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日誉衡药业涨7.78%，收盘报3.74元，换手率24.14%，成交量507.65万手，成交额18.68亿元。重仓誉衡药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的中证2000ETF广发。中证2000ETF广发目前规模为0.76亿元，最新净值1.4595，较上一交易日上涨1.78%，近一年上涨4.9%。中证2000ETF广发的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100020985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0188","BK0239","BK0060","BK0028","560220","BK0077","BK0095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667263827","title":"股市必读：誉衡药业新发布《2026年第三次临时股东会法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667263827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667263827?lang=zh_cn&edition=full","pubTime":"2026-09-14 04:07","pubTimestamp":1789330030,"startTime":"0","endTime":"0","summary":"公司公告汇总：誉衡药业2026年第三次临时股东大会审议通过续聘上会会计师事务所、修订公司章程及回购注销离职人员限制性股票三项议案，其中后两项为特别决议事项并获2/3以上表决权通过。公司公告汇总2026年第三次临时股东会法律意见书北京市京轩律师事务所出具法律意见书，认为哈尔滨誉衡药业股份有限公司2026年第三次临时股东大会的召集、召开程序符合相关法律法规及公司章程规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0095","BK0077","002437","BK0060","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666257891","title":"誉衡药业（002437）披露2026年第三次临时股东会决议公告，9月11日股价下跌2.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666257891","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666257891?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:35","pubTimestamp":1789137318,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，誉衡药业报收于3.47元，较前一交易日下跌2.25%，最新总市值为77.38亿元。该股当日开盘3.51元，最高3.59元，最低3.41元，成交额达9.01亿元，换手率为12.35%。公司于近日披露《2026年第三次临时股东会决议公告》。公告显示，哈尔滨誉衡药业股份有限公司于2026年9月11日召开2026年第三次临时股东会，会议采用现场与网络投票结合方式，出席股东及股东代表共1,948人，代表股份323,778,134股，占公司有表决权总股份的14.5201%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100050653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0239","BK0095","BK0028","BK0077","BK0188","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666857705","title":"9月9日誉衡药业跌8.19%，中证2000ETF广发基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2666857705","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666857705?lang=zh_cn&edition=full","pubTime":"2026-09-09 16:37","pubTimestamp":1788943074,"startTime":"0","endTime":"0","summary":"证券之星消息，9月9日誉衡药业跌8.19%，收盘报3.7元，换手率21.3%，成交量447.96万手，成交额16.96亿元。重仓誉衡药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的中证2000ETF广发。中证2000ETF广发目前规模为0.76亿元，最新净值1.4584，较上一交易日上涨0.83%，近一年上涨6.41%。中证2000ETF广发的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900027769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["560220","BK0028","BK0077","BK0095","BK0239","BK0188","002437","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664820640","title":"9月3日誉衡药业跌6.18%，中证2000ETF广发基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664820640","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664820640?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:39","pubTimestamp":1788424753,"startTime":"0","endTime":"0","summary":"证券之星消息，9月3日誉衡药业跌6.18%，收盘报4.25元，换手率29.65%，成交量623.37万手，成交额26.28亿元。重仓誉衡药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的中证2000ETF广发。中证2000ETF广发目前规模为0.76亿元，最新净值1.4421，较上一交易日下跌0.86%，近一年上涨5.31%。中证2000ETF广发的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300030111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002437","BK0077","BK0028","BK0060","BK0188","560220","BK0095"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664902688","title":"9月2日誉衡药业（002437）龙虎榜数据：机构净卖出6523.81万元，北向资金净买入4.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2664902688","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664902688?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:32","pubTimestamp":1788341560,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年9月2日公布的交易公开信息显示，誉衡药业因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第4次上榜。截至2026年9月2日收盘，誉衡药业报收于4.53元，上涨4.14%，换手率32.5%，成交量683.44万手，成交额31.16亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出6523.81万元，北向资金合计净买入4.91万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200031268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0095","BK0239","002437","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663141079","title":"8月31日誉衡药业（002437）龙虎榜数据：机构净卖出2.15亿元，北向资金净卖出6241.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663141079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663141079?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:38","pubTimestamp":1788169097,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月31日公布的交易公开信息显示，誉衡药业因日跌幅偏离值达到7%的前5只证券，日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第5次上榜。截至2026年8月31日收盘，誉衡药业报收于4.37元，下跌10.08%，跌停，换手率31.7%，成交量666.5万手，成交额29.43亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出2.15亿元，北向资金合计净卖出6241.53万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100024253.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0060","BK0095","BK0239","002437","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663759970","title":"8月31日誉衡药业跌10.08%，中证2000ETF广发基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663759970","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663759970?lang=zh_cn&edition=full","pubTime":"2026-08-31 16:42","pubTimestamp":1788165759,"startTime":"0","endTime":"0","summary":"证券之星消息，8月31日誉衡药业跌10.08%，收盘报4.37元，换手率31.7%，成交量666.5万手，成交额29.43亿元。重仓誉衡药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为广发基金的中证2000ETF广发。中证2000ETF广发目前规模为0.76亿元，最新净值1.4469，较上一交易日下跌0.02%，近一年上涨3.19%。中证2000ETF广发的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100022392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002437","BK0095","BK0239","BK0077","560220","BK0060","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663029710","title":"异动快报：誉衡药业（002437）8月31日11点12分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2663029710","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663029710?lang=zh_cn&edition=full","pubTime":"2026-08-31 11:15","pubTimestamp":1788146122,"startTime":"0","endTime":"0","summary":"证券之星8月31日盘中消息，11点12分誉衡药业（002437）触及跌停板。其所属行业化学制药目前下跌。领涨股为赛托生物。该股为民营医院，维生素，基因测序概念热股。8月28日的资金流向数据方面，主力资金净流入1.75亿元，占总成交额4.86%，游资资金净流出1.8亿元，占总成交额4.98%，散户资金净流入458.07万元，占总成交额0.13%。近5日资金流向一览见下表：誉衡药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100010059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0095","BK0188","BK0060","BK0028","BK0239","002437","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662960020","title":"誉衡药业（002437）披露全资子公司签署《终止协议》公告，8月28日股价上涨9.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662960020","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662960020?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:01","pubTimestamp":1787925674,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，誉衡药业报收于4.86元，较前一交易日上涨9.95%，最新总市值为108.37亿元。近日，哈尔滨誉衡药业股份有限公司披露关于全资子公司签署《终止协议》的公告。公告显示，公司全资子公司天津誉衡博达科技有限公司与卫材（中国）药业有限公司于2026年8月28日签署《终止协议》，双方同意自2026年6月29日起解除关于甲钴胺注射液的独家推广服务合作关系，并将按约定推进后续交接及结算事宜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800053371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0077","BK0095","BK0028","BK0239","002437","BK0188"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792364443935,"stockEarnings":[{"period":"1week","weight":-0.0434},{"period":"1month","weight":0.0413},{"period":"3month","weight":0.2007},{"period":"6month","weight":-0.0511},{"period":"1year","weight":0.0929},{"period":"ytd","weight":0.1498}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.0127},{"period":"6month","weight":-0.0827},{"period":"1year","weight":-0.0511},{"period":"ytd","weight":-0.0636}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"哈尔滨誉衡药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"115700人(较上一季度增加25.49%)","perCapita":"18189股","listingDate":"2010-06-23","address":"黑龙江省哈尔滨市呼兰区利民经济技术开发区北京路29号","registeredCapital":"222986万元","survey":" 哈尔滨誉衡药业股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是维生素类药物、心脑血管药物、骨科药物、电解质类药物、抗肿瘤药物、抗感染药物、其他用药领域、糖尿病类药物、镇痛类药物。","listedPrice":50},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"誉衡药业(002437)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供誉衡药业(002437)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"誉衡药业,002437,誉衡药业股票,誉衡药业股票老虎,誉衡药业股票老虎国际,誉衡药业行情,誉衡药业股票行情,誉衡药业股价,誉衡药业股市,誉衡药业股票价格,誉衡药业股票交易,誉衡药业股票购买,誉衡药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"誉衡药业(002437)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供誉衡药业(002437)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}